Guest blog: Biotime and Geron combine to form Asterias Biotherapeutics

Biotime and Geron combine to form Asterias Biotherapeutics: A star player in the field of regenerative medicine. Dr Thomas Okarma is the President and CEO of Asterias Biotherapeutics Incorporated, a development stage biotechnology company based in California. Asterias is focusing on the commercialisation of proof of concept (POC) stage cell therapies having acquired and combined the vast expertise and patent …